Virtual Education

Presentations from a CML Opinion Leader Meeting

We are pleased to make available a new series of presentations from the COLT Meeting 2014, an annual CML Opinion Leader Training that took place in Adelaide (Australia). Modules currently featured include; high risk CML, optimizing therapy, front line therapy in CML chronic phase and new developments in CML - all presented by leaders in the field. 

Dr David Ross            Dr Agnes Yong

Session 4: New developments in CML

• Is CML a curable disease? 
  (Dr David Ross)
• Transplant and immunotherapy in CML
  (Dr Agnes Yong)

Is CML a curable disease?

Dr David Ross - SA Pathology, University of Adelaide

• Discussion on 'cure' in CML treatment
• Complete molecular response in CML
• Allografting
• Stopping imatinib
• Results from the ALLG CML8 study
• Stopping of 2G TKI 
• Dasatinib after imatinib failure

Transplant and immunotherapy in CML
Dr Agnes Yong - SA Pathology, University of Adelaide

• Overview of allogeneic stem cell transplantation in CML
• Which CML patient needs transplant?
• Which conditioning regime for alloSCT?
• Role of TKI's after transplant
• Future directions: immunotherapy
• Leukemia associated antigens
• Immunotherapy targeting single protein